$408 Million is the total value of AIGH Capital Management LLC's 83 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 65.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PDFS | Sell | PDF SOLUTIONS INC | $23,963,000 | -25.0% | 859,812 | -14.4% | 5.88% | -39.7% |
PLAB | Sell | PHOTRONICS INC | $20,699,000 | -11.5% | 1,219,740 | -1.7% | 5.08% | -28.8% |
MRAM | Sell | EVERSPIN TECHNOLOGIES INC | $11,186,000 | -36.3% | 1,284,249 | -17.4% | 2.74% | -48.8% |
EDAP | Sell | EDAP TMS S Asponsored adr | $4,548,000 | -36.6% | 627,316 | -47.7% | 1.12% | -49.1% |
PDSB | Sell | PDS BIOTECHNOLOGY CORP | $1,750,000 | -29.9% | 282,609 | -8.3% | 0.43% | -43.6% |
XFOR | Sell | X4 PHARMACEUTICALS INC | $1,746,000 | -47.9% | 997,719 | -31.9% | 0.43% | -58.1% |
BLIN | Sell | BRIDGELINE DIGITAL INC | $1,261,000 | -36.4% | 660,521 | -24.7% | 0.31% | -48.8% |
FKWL | Sell | FRANKLIN WIRELESS CORP | $394,000 | -76.9% | 98,826 | -74.7% | 0.10% | -81.3% |
Exit | COGNITION THERAPEUTICS INC | $0 | – | -25,496 | -100.0% | -0.05% | – | |
Exit | DERMATA THERAPEUTICS INCcall | $0 | – | -175,000 | -100.0% | -0.09% | – | |
Exit | PETVIVO HLDGS INCcall | $0 | – | -100,000 | -100.0% | -0.12% | – | |
NMTC | Exit | NEUROONE MED TECHNOLOGIES CO | $0 | – | -475,000 | -100.0% | -0.28% | – |
BWAY | Exit | BRAINSWAY LTDsponsored ads | $0 | – | -207,847 | -100.0% | -0.49% | – |
Exit | CONTEXT THERAPEUTICS INC | $0 | – | -762,721 | -100.0% | -0.62% | – | |
EMKR | Exit | EMCORE CORP | $0 | – | -293,349 | -100.0% | -0.62% | – |
ALNA | Exit | ALLENA PHARMACEUTICALS | $0 | – | -4,000,000 | -100.0% | -0.72% | – |
Exit | ALIMERA SCIENCES INC | $0 | – | -497,639 | -100.0% | -0.78% | – | |
RNAZ | Exit | TRANSCODE THERAPEUTICS INC | $0 | – | -1,270,600 | -100.0% | -0.98% | – |
HTGM | Exit | HTG MOLECULAR DIAGNOSTICS IN | $0 | – | -612,000 | -100.0% | -1.01% | – |
OIIM | Exit | O2MICRO INTERNATIONAL LIMITEspons adr | $0 | – | -871,051 | -100.0% | -1.20% | – |
LTRX | Exit | LANTRONIX INC | $0 | – | -688,309 | -100.0% | -1.64% | – |
MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -337,917 | -100.0% | -1.64% | – |
Exit | PARABELLUM ACQUISITION CORPcall | $0 | – | -589,286 | -100.0% | -1.75% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
SCPHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
FRANKLIN WIRELESS CORP | 11 | Q3 2023 | 2.9% |
IDEAL PWR INC | 11 | Q3 2023 | 2.5% |
MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
LIGHTPATH TECHNOLOGIES INC | 10 | Q3 2023 | 3.0% |
MYOMO INC | 10 | Q3 2023 | 1.3% |
DZS INC | 9 | Q1 2023 | 7.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.